Chinese scientists achieve diabetes cure through innovative cell therapy, detailed in Cell Discovery. Patient, treated in July 2021, no longer requires insulin after eleven weeks, and is now medication-free for 33 months. The breakthrough, praised by Timothy Kieffer, signifies a major advancement in diabetes treatment. This novel approach utilizes the body's regenerative abilities and could alleviate China's healthcare burden. Further studies are needed for validation.
I don’t exactly subscribe to the conspiracy but I can understand it as it’s related to “planned obsolescence.” Companies don’t want to sell you a quality product that will last “forever” they want to sell you something that’s just good enough to work for a bit, but will absolutely break or be replaced very soon so you become a repeat customer as opposed to a one time customer.
The same logic applies here with the medication, why would they sell something once even if there were new future customers, if they could instead have everyone on a “subscription” of sorts?
The conspiracy exists because we see it play out in every other facet of our society/economy. Everything is becoming a subscription, you don’t own anything, every product a corporation makes is almost complete garbage, etc… I’m not sure I believe it 100% but I wouldn’t in the slightest bit be surprised to find out that actually was the case.
There is no grand secret conspiracy. Why? The more people involved in a conspiracy, the more likely it will leak out. A conspiracy between two people may never get it, a conspiracy between a hundred people will have someone slip up in a few years at most, but an international conspiracy involving millions of people with disparate interests wouldn’t stay secret for a second.
What we’re seeing isn’t a conspiracy as such. It’s a conversation happening in the open about “business models” and “revenue streams”. It’s also based on customer expectations. There are definitely markets out there for the repairable, buy it for life goods, but there’s just not nearly as big as the customer who upgrades their phone every two years. But obviously that’s going to be different for diabetes. Reliably being able to repair pancreatic cells would be huge. If the companies selling insulin tried to internally stifle research to avoid cannibalizing their insulin business, other companies have an enormous incentive to take a crack at it.